Given the pivotal role of PKM2 in many cancers, compounds that tetramerize PKM2 have been developed to reduce aerobic glycolysis and prevent its malignant nuclear activity (Figure 7A; Chen et al., 2011; Li et al., 2018; Zhao et al., 2018). This evidence concerns the gene PKM and cancer.